{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T21:07:44Z","timestamp":1784668064459,"version":"3.55.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,12]],"date-time":"2019-11-12T00:00:00Z","timestamp":1573516800000},"content-version":"vor","delay-in-days":2110,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1093\/annonc\/mdt547","type":"journal-article","created":{"date-parts":[[2013,12,31]],"date-time":"2013-12-31T01:15:38Z","timestamp":1388452538000},"page":"404-408","source":"Crossref","is-referenced-by-count":75,"title":["Activity of temozolomide in patients with advanced chemorefractory colorectal cancer and MGMT promoter methylation"],"prefix":"10.1016","volume":"25","author":[{"given":"F.","family":"Pietrantonio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Perrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"de Braud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Castano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Maggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Bossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Gevorgyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Biondani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Pacifici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Busico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Gariboldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Festinese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Tamborini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Di Bartolomeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdt547_bb0010","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.ctrv.2012.12.011","article-title":"Targeted therapy in metastatic colorectal cancer\u2014an example of personalised medicine in action","volume":"39","author":"Heinemann","year":"2013","journal-title":"Cancer Treat Rev"},{"key":"10.1093\/annonc\/mdt547_bb0015","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0140-6736(12)61900-X","article-title":"Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial","volume":"381","author":"Grothey","year":"2013","journal-title":"Lancet"},{"key":"10.1093\/annonc\/mdt547_bb0020","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1093\/jnci\/dji275","article-title":"MGMT promoter methylation and field defect in sporadic colorectal cancer","volume":"97","author":"Shen","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"10.1093\/annonc\/mdt547_bb0025","first-page":"2368","article-title":"Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is associated with G to A mutations in K-ras in colorectal tumorigenesis","volume":"60","author":"Esteller","year":"2000","journal-title":"Cancer Res"},{"key":"10.1093\/annonc\/mdt547_bb0030","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1383-5742(00)00017-X","article-title":"Repair of O(6)-alkylguanine by alkyltransferases","volume":"462","author":"Pegg","year":"2000","journal-title":"Mutat Res"},{"key":"10.1093\/annonc\/mdt547_bb0035","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0079-6603(01)68088-7","article-title":"BER, MGMT, and MMR in defense against alkylation-induced genotoxicity and apoptosis","volume":"68","author":"Kaina","year":"2001","journal-title":"Prog Nucleic Acid Res Mol Biol"},{"key":"10.1093\/annonc\/mdt547_bb0040","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1093\/carcin\/16.6.1385","article-title":"Localization of methylation sites in the human O6-methylguanine-DNA methyltransferase promoter: correlation with gene suppression","volume":"16","author":"Qian","year":"1995","journal-title":"Carcinogenesis"},{"key":"10.1093\/annonc\/mdt547_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/sj.onc.1207316","article-title":"Generating mutations but providing chemosensitivity: the role of O6-methylguanine DNA methyltransferase in human cancer","volume":"23","author":"Esteller","year":"2004","journal-title":"Oncogene"},{"key":"10.1093\/annonc\/mdt547_bb0050","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1056\/NEJMoa043331","article-title":"MGMT gene silencing and benefit from temozolomide in glioblastoma","volume":"352","author":"Hegi","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdt547_bb0055","doi-asserted-by":"crossref","first-page":"4877","DOI":"10.1200\/JCO.2009.26.5983","article-title":"Pilot study using molecular profiling of patients\u2019 tumors to find potential targets and select treatments for their refractory cancers","volume":"28","author":"Von Hoff","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdt547_bb0060","doi-asserted-by":"crossref","first-page":"e262","DOI":"10.1200\/JCO.2010.32.0242","article-title":"Response to temozolomide in patients with metastatic colorectal cancer with loss of MGMT expression: a new approach in the era of personalized medicine?","volume":"29","author":"Shacham-Shmueli","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdt547_bb0065","doi-asserted-by":"crossref","first-page":"9821","DOI":"10.1073\/pnas.93.18.9821","article-title":"Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands","volume":"93","author":"Herman","year":"1996","journal-title":"Proc Natl Acad Sci"},{"key":"10.1093\/annonc\/mdt547_bb0070","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1093\/annonc\/mdn541","article-title":"PI3KCA\/PTEN deregulation contributes to impaired responses to cetuximab in metastatic colorectal cancer patients","volume":"20","author":"Perrone","year":"2009","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdt547_bb0075","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1215\/15228517-2009-003","article-title":"PDGFRA, PDGFRB, EGFR, and downstream signaling activation in malignant peripheral nerve sheath tumor","volume":"11","author":"Perrone","year":"2009","journal-title":"Neuro Oncol"},{"key":"10.1093\/annonc\/mdt547_bb0080","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1053\/gast.2002.37070","article-title":"Evaluation of tumor microsatellite instability using five quasimonomorphic mononucleotide repeats and pentaplex PCR","volume":"123","author":"Suraweera","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1093\/annonc\/mdt547_bb0085","doi-asserted-by":"crossref","first-page":"8424","DOI":"10.1073\/pnas.1431692100","article-title":"Understanding the function\u2013structure and function\u2013mutation relationships of p53 tumor suppressor protein by high-resolution missense mutation analysis","volume":"100","author":"Kato","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1093\/annonc\/mdt547_bb0090","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1200\/JCO.2006.10.3317","article-title":"Successful treatment of leptomeningeal disease in colorectal cancer with a regimen of bevacizumab, temozolomide, and irinotecan","volume":"25","author":"Ku","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdt547_bb0095","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1038\/sj.bjc.6604366","article-title":"A phase II trial of lomeguatrib and temozolomide in metastatic colorectal cancer","volume":"98","author":"Khan","year":"2008","journal-title":"Br J Cancer"},{"key":"10.1093\/annonc\/mdt547_bb0100","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1158\/1078-0432.CCR-12-3518","article-title":"Promoter CpG island hypermethylation of the DNA repair enzyme MGMT predicts clinical response to dacarbazine in a phase II study for metastatic colorectal cancer","volume":"19","author":"Amatu","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1093\/annonc\/mdt547_bb0105","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1158\/1535-7163.MCT-12-0710","article-title":"A phase II study of temozolomide in patients with advanced aerodigestive tract and colorectal cancers and methylation of the O6-methylguanine-DNA methyltransferase promoter","volume":"12","author":"Hochhauser","year":"2013","journal-title":"Mol Cancer Ther"},{"key":"10.1093\/annonc\/mdt547_bb0110","first-page":"827","article-title":"Methylation of O-6-methylguanine DNA methyltransferase characterizes a subset of colorectal cancer with low-level DNA microsatellite instability","volume":"61","author":"Whitehall","year":"2001","journal-title":"Cancer Res"},{"key":"10.1093\/annonc\/mdt547_bb0115","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1056\/NEJMoa022289","article-title":"Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer","volume":"349","author":"Ribic","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdt547_bb0120","doi-asserted-by":"crossref","first-page":"4622","DOI":"10.1158\/1078-0432.CCR-08-3012","article-title":"MSH6 mutations arise in glioblastomas during temozolomide therapy and mediate temozolomide resistance","volume":"15","author":"Yip","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1093\/annonc\/mdt547_bb0125","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1111\/j.1365-2559.2011.03821.x","article-title":"Frequent mutations of KRAS in addition to BRAF in colorectal serrated adenocarcinoma","volume":"58","author":"Stefanius","year":"2011","journal-title":"Histopathology"},{"key":"10.1093\/annonc\/mdt547_bb0130","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1002\/stem.753","article-title":"MEK-ERK signaling dictates DNA-repair gene MGMT expression and temozolomide resistance of stem-like glioblastoma cells via the MDM2-p53 axis","volume":"29","author":"Sato","year":"2011","journal-title":"Stem Cells"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419364634?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419364634?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/25\/2\/404\/16699413\/mdt547.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T07:36:04Z","timestamp":1624520164000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419364634"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S0923753419364634"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdt547","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]}}}